

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.11977157 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.16309885 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.72299808 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.72299808 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.47286703 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.41521303 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.94214175 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.94214175 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.83084410 |
| 10 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.73743830 |
| 11 | leukocyte aggregation (GO:0070486) | 4.58852633 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.56975674 |
| 13 | negative T cell selection (GO:0043383) | 4.55946632 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.51938406 |
| 15 | positive thymic T cell selection (GO:0045059) | 4.41857461 |
| 16 | mast cell activation (GO:0045576) | 4.40028872 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 4.38335282 |
| 18 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.26628424 |
| 19 | interferon-gamma production (GO:0032609) | 4.23897012 |
| 20 | T cell migration (GO:0072678) | 4.23487488 |
| 21 | detection of other organism (GO:0098543) | 4.22738125 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.18035850 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.18035850 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.18035850 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 4.18035850 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 4.18035850 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 4.18035850 |
| 28 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.09736689 |
| 29 | regulation of B cell differentiation (GO:0045577) | 4.08753728 |
| 30 | detection of bacterium (GO:0016045) | 4.05552059 |
| 31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.03697788 |
| 32 | respiratory burst (GO:0045730) | 4.00391107 |
| 33 | microglial cell activation (GO:0001774) | 4.00062045 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.99917707 |
| 35 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.99631368 |
| 36 | cellular extravasation (GO:0045123) | 3.98991780 |
| 37 | cellular response to interleukin-15 (GO:0071350) | 3.92631993 |
| 38 | detection of molecule of bacterial origin (GO:0032490) | 3.91775497 |
| 39 | response to interleukin-15 (GO:0070672) | 3.89501350 |
| 40 | sequestering of actin monomers (GO:0042989) | 3.89219698 |
| 41 | detection of external biotic stimulus (GO:0098581) | 3.84864971 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 3.80463134 |
| 43 | thymic T cell selection (GO:0045061) | 3.79263591 |
| 44 | positive regulation of leukocyte degranulation (GO:0043302) | 3.79170755 |
| 45 | regulation of gamma-delta T cell activation (GO:0046643) | 3.76799804 |
| 46 | positive T cell selection (GO:0043368) | 3.75477758 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.75078762 |
| 48 | positive regulation of antigen processing and presentation (GO:0002579) | 3.74731111 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 3.72747409 |
| 50 | B cell receptor signaling pathway (GO:0050853) | 3.70696590 |
| 51 | positive regulation of chemokine secretion (GO:0090197) | 3.69380339 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 3.65654093 |
| 53 | positive regulation of mast cell activation (GO:0033005) | 3.65244833 |
| 54 | hepatocyte apoptotic process (GO:0097284) | 3.62743684 |
| 55 | regulation of tolerance induction (GO:0002643) | 3.60674372 |
| 56 | positive regulation of lamellipodium assembly (GO:0010592) | 3.49484884 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.49241965 |
| 58 | regulation of T cell tolerance induction (GO:0002664) | 3.47386512 |
| 59 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.45674162 |
| 60 | mature B cell differentiation (GO:0002335) | 3.45378909 |
| 61 | macrophage activation (GO:0042116) | 3.44585650 |
| 62 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.44215252 |
| 63 | B cell mediated immunity (GO:0019724) | 3.42805435 |
| 64 | tolerance induction (GO:0002507) | 3.40500301 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.40311955 |
| 66 | T cell selection (GO:0045058) | 3.40271527 |
| 67 | detection of biotic stimulus (GO:0009595) | 3.39453944 |
| 68 | neutrophil activation (GO:0042119) | 3.38857411 |
| 69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.36545094 |
| 70 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.36545094 |
| 71 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.36181221 |
| 72 | mast cell activation involved in immune response (GO:0002279) | 3.35286929 |
| 73 | mast cell degranulation (GO:0043303) | 3.35286929 |
| 74 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.35165970 |
| 75 | myeloid dendritic cell activation (GO:0001773) | 3.32790027 |
| 76 | negative regulation of phagocytosis (GO:0050765) | 3.26749941 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 3.26462284 |
| 78 | T cell receptor signaling pathway (GO:0050852) | 3.26451341 |
| 79 | T cell costimulation (GO:0031295) | 3.26055559 |
| 80 | cellular response to zinc ion (GO:0071294) | 3.25358006 |
| 81 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.24622469 |
| 82 | negative regulation of granulocyte differentiation (GO:0030853) | 3.23191263 |
| 83 | regulation of antigen processing and presentation (GO:0002577) | 3.22427890 |
| 84 | lymphocyte costimulation (GO:0031294) | 3.20802650 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.20727116 |
| 86 | actin nucleation (GO:0045010) | 3.19482791 |
| 87 | positive regulation of interferon-alpha production (GO:0032727) | 3.19005898 |
| 88 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.17321132 |
| 89 | pinocytosis (GO:0006907) | 3.16039770 |
| 90 | granulocyte activation (GO:0036230) | 3.12727306 |
| 91 | mature B cell differentiation involved in immune response (GO:0002313) | 3.11710821 |
| 92 | positive regulation of macrophage differentiation (GO:0045651) | 3.09168708 |
| 93 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.08931355 |
| 94 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.08931355 |
| 95 | neutrophil mediated immunity (GO:0002446) | 3.07885579 |
| 96 | cellular defense response (GO:0006968) | 3.07548482 |
| 97 | regulation of interferon-alpha production (GO:0032647) | 3.06786543 |
| 98 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.03645976 |
| 99 | leukocyte degranulation (GO:0043299) | 3.02290674 |
| 100 | response to host immune response (GO:0052572) | 3.02188579 |
| 101 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.02188579 |
| 102 | myeloid leukocyte activation (GO:0002274) | 3.02001449 |
| 103 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01520476 |
| 104 | positive regulation of lamellipodium organization (GO:1902745) | 3.01142829 |
| 105 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.00391689 |
| 106 | regulation of mast cell activation (GO:0033003) | 2.99611890 |
| 107 | myeloid dendritic cell differentiation (GO:0043011) | 2.98262102 |
| 108 | energy homeostasis (GO:0097009) | 2.97589642 |
| 109 | response to peptidoglycan (GO:0032494) | 2.97504991 |
| 110 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97019278 |
| 111 | cellular response to interferon-gamma (GO:0071346) | 2.96272215 |
| 112 | defense response to protozoan (GO:0042832) | 2.95885230 |
| 113 | regulation of mast cell degranulation (GO:0043304) | 2.95288176 |
| 114 | leukocyte cell-cell adhesion (GO:0007159) | 2.94751036 |
| 115 | regulation of hypersensitivity (GO:0002883) | 2.94560750 |
| 116 | positive regulation of regulated secretory pathway (GO:1903307) | 2.93322015 |
| 117 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.93268730 |
| 118 | negative regulation of T cell mediated immunity (GO:0002710) | 2.91232286 |
| 119 | cellular response to interferon-beta (GO:0035458) | 2.90318240 |
| 120 | response to protozoan (GO:0001562) | 2.90007309 |
| 121 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.89701169 |
| 122 | glycosphingolipid catabolic process (GO:0046479) | 2.88633545 |
| 123 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.87598403 |
| 124 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.86772522 |
| 125 | positive regulation of mast cell degranulation (GO:0043306) | 2.86247010 |
| 126 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86247010 |
| 127 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.85909136 |
| 128 | response to interferon-gamma (GO:0034341) | 2.80720275 |
| 129 | histamine secretion (GO:0001821) | 2.79313586 |
| 130 | purine nucleotide salvage (GO:0032261) | 2.76281028 |
| 131 | myeloid leukocyte mediated immunity (GO:0002444) | 2.75931325 |
| 132 | homocysteine metabolic process (GO:0050667) | 2.75509545 |
| 133 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.73715227 |
| 134 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.73643439 |
| 135 | adenosine metabolic process (GO:0046085) | 2.72090906 |
| 136 | glycolipid catabolic process (GO:0019377) | 2.71256862 |
| 137 | positive regulation of tolerance induction (GO:0002645) | 2.68697573 |
| 138 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.66618070 |
| 139 | negative regulation of acute inflammatory response (GO:0002674) | 2.66504143 |
| 140 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.65941744 |
| 141 | neutrophil chemotaxis (GO:0030593) | 2.64655570 |
| 142 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.64487390 |
| 143 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.64487390 |
| 144 | regulation of regulated secretory pathway (GO:1903305) | 2.63764018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.43126867 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.24344316 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.20254477 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.73141607 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.08926625 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.05873090 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.89567771 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.79418319 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63743556 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.43753994 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18112590 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.13489064 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.12434087 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.04648868 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.00370617 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.99468025 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.92329137 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.92191116 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.88087765 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.78749692 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.75049076 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.72225508 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68402742 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.57754665 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.56442517 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.39360153 |
| 27 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.32641178 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31200570 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 2.30778665 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 2.29794163 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27960980 |
| 32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.24923184 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 2.19555879 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.18211920 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 2.15415480 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09492887 |
| 37 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.06775588 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.93824790 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.90696448 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90435120 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.85202388 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.84535140 |
| 43 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.82482936 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81777417 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73325865 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69725334 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.69683969 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68949896 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68617805 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64984141 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63107242 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54722187 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.51810084 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49806975 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46437963 |
| 56 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43666435 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43061766 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41217046 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33732025 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31919597 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31779711 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30688634 |
| 63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.30359555 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30168380 |
| 65 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27489508 |
| 66 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.24043612 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.21898564 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20611470 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19958458 |
| 70 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19863449 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15604599 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15194029 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14797203 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14082713 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13751549 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13556815 |
| 77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12687249 |
| 78 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07729455 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05906954 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05616790 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05149841 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.04341286 |
| 83 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.03884086 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02285996 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99992343 |
| 86 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99484971 |
| 87 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97414034 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97070392 |
| 89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96699433 |
| 90 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96041753 |
| 91 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95923453 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95747060 |
| 93 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.95541991 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.94335135 |
| 95 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93934115 |
| 96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92922990 |
| 97 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.92647097 |
| 98 | GATA3_26560356_Chip-Seq_TH1_Human | 0.89462838 |
| 99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85674923 |
| 100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.84577715 |
| 101 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.83739734 |
| 102 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83634757 |
| 103 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83619222 |
| 104 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.81838932 |
| 105 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.81423887 |
| 106 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81375364 |
| 107 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81071799 |
| 108 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.79878731 |
| 109 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78917203 |
| 110 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.78540171 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78477208 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78391358 |
| 113 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.78082257 |
| 114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77748024 |
| 115 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77143443 |
| 116 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.76194638 |
| 117 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76191509 |
| 118 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.75189329 |
| 119 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74553655 |
| 120 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74275322 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73944341 |
| 122 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72041500 |
| 123 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.70830797 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69969572 |
| 125 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.69651451 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.82033593 |
| 2 | MP0005671_abnormal_response_to | 4.36174359 |
| 3 | MP0006082_CNS_inflammation | 3.17750277 |
| 4 | MP0005000_abnormal_immune_tolerance | 3.15414388 |
| 5 | MP0003436_decreased_susceptibility_to | 3.11688360 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.09759379 |
| 7 | MP0009785_altered_susceptibility_to | 3.06494259 |
| 8 | MP0001800_abnormal_humoral_immune | 2.99547119 |
| 9 | MP0002419_abnormal_innate_immunity | 2.97136723 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.96958627 |
| 11 | MP0005025_abnormal_response_to | 2.89780678 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.88628688 |
| 13 | MP0000685_abnormal_immune_system | 2.86869369 |
| 14 | MP0002723_abnormal_immune_serum | 2.86657066 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.84659169 |
| 16 | MP0001819_abnormal_immune_cell | 2.84059954 |
| 17 | MP0001790_abnormal_immune_system | 2.74245157 |
| 18 | MP0005387_immune_system_phenotype | 2.74245157 |
| 19 | MP0003303_peritoneal_inflammation | 2.64282231 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.50560733 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.47543217 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.46720198 |
| 23 | MP0002398_abnormal_bone_marrow | 2.35270023 |
| 24 | MP0003724_increased_susceptibility_to | 2.33755603 |
| 25 | MP0000716_abnormal_immune_system | 2.24062479 |
| 26 | MP0002405_respiratory_system_inflammati | 2.22462290 |
| 27 | MP0003172_abnormal_lysosome_physiology | 2.22136318 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.16125347 |
| 29 | MP0002396_abnormal_hematopoietic_system | 2.11524646 |
| 30 | MP0005360_urolithiasis | 2.11425425 |
| 31 | MP0004510_myositis | 2.05394335 |
| 32 | MP0002006_tumorigenesis | 2.04184321 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.97126066 |
| 34 | MP0001853_heart_inflammation | 1.94497810 |
| 35 | MP0002722_abnormal_immune_system | 1.92728224 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.84603371 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.83511466 |
| 38 | MP0002429_abnormal_blood_cell | 1.82454974 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.81486271 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.80154822 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.75949319 |
| 42 | MP0001873_stomach_inflammation | 1.71707505 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.65104832 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.63686951 |
| 45 | MP0005310_abnormal_salivary_gland | 1.61134546 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.60940885 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.60059842 |
| 48 | MP0004947_skin_inflammation | 1.56980944 |
| 49 | MP0005670_abnormal_white_adipose | 1.53321834 |
| 50 | MP0008469_abnormal_protein_level | 1.51554133 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.49603709 |
| 52 | MP0000343_altered_response_to | 1.49572940 |
| 53 | MP0000858_altered_metastatic_potential | 1.46831615 |
| 54 | MP0003866_abnormal_defecation | 1.45667685 |
| 55 | MP0003448_altered_tumor_morphology | 1.42734364 |
| 56 | MP0002933_joint_inflammation | 1.36499990 |
| 57 | MP0005451_abnormal_body_composition | 1.25841235 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.23881660 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.23758128 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.19525214 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.19183932 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.19183932 |
| 63 | MP0000516_abnormal_urinary_system | 1.18579634 |
| 64 | MP0005367_renal/urinary_system_phenotyp | 1.18579634 |
| 65 | MP0001851_eye_inflammation | 1.17882768 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.15508392 |
| 67 | MP0003075_altered_response_to | 1.13437877 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 1.11841517 |
| 69 | MP0005164_abnormal_response_to | 1.11155310 |
| 70 | MP0009764_decreased_sensitivity_to | 1.05346602 |
| 71 | MP0008995_early_reproductive_senescence | 1.04671907 |
| 72 | MP0009840_abnormal_foam_cell | 1.02669436 |
| 73 | MP0004883_abnormal_blood_vessel | 1.01596345 |
| 74 | MP0005166_decreased_susceptibility_to | 1.00533263 |
| 75 | MP0000490_abnormal_crypts_of | 1.00277262 |
| 76 | MP0005646_abnormal_pituitary_gland | 0.99454591 |
| 77 | MP0000013_abnormal_adipose_tissue | 0.92547942 |
| 78 | MP0000569_abnormal_digit_pigmentation | 0.92367392 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.90470274 |
| 80 | MP0001765_abnormal_ion_homeostasis | 0.90068371 |
| 81 | MP0001661_extended_life_span | 0.88995122 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 0.88879687 |
| 83 | MP0005332_abnormal_amino_acid | 0.88706842 |
| 84 | MP0001756_abnormal_urination | 0.88123240 |
| 85 | MP0000604_amyloidosis | 0.86910301 |
| 86 | MP0009278_abnormal_bone_marrow | 0.85996893 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.85799015 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.85623463 |
| 89 | MP0009763_increased_sensitivity_to | 0.82018460 |
| 90 | MP0005085_abnormal_gallbladder_physiolo | 0.81166488 |
| 91 | MP0003252_abnormal_bile_duct | 0.76429642 |
| 92 | MP0008004_abnormal_stomach_pH | 0.76218840 |
| 93 | MP0003195_calcinosis | 0.76190490 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.75746575 |
| 95 | MP0003045_fibrosis | 0.74957010 |
| 96 | MP0000249_abnormal_blood_vessel | 0.73924566 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.73856230 |
| 98 | MP0003828_pulmonary_edema | 0.72904975 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.71212970 |
| 100 | MP0008873_increased_physiological_sensi | 0.70819412 |
| 101 | MP0003787_abnormal_imprinting | 0.69792097 |
| 102 | MP0002009_preneoplasia | 0.68786984 |
| 103 | MP0005647_abnormal_sex_gland | 0.68035993 |
| 104 | MP0004147_increased_porphyrin_level | 0.67964681 |
| 105 | MP0008007_abnormal_cellular_replicative | 0.67889989 |
| 106 | MP0002138_abnormal_hepatobiliary_system | 0.66308657 |
| 107 | MP0003795_abnormal_bone_structure | 0.64024511 |
| 108 | MP0001663_abnormal_digestive_system | 0.60247300 |
| 109 | MP0003690_abnormal_glial_cell | 0.59832268 |
| 110 | MP0002928_abnormal_bile_duct | 0.59000418 |
| 111 | MP0005390_skeleton_phenotype | 0.59000347 |
| 112 | MP0004381_abnormal_hair_follicle | 0.57785749 |
| 113 | MP0000371_diluted_coat_color | 0.54216434 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.51418970 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.50320213 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.49682667 |
| 117 | MP0010307_abnormal_tumor_latency | 0.49451398 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.47521582 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.45010030 |
| 120 | MP0005076_abnormal_cell_differentiation | 0.42782825 |
| 121 | MP0003566_abnormal_cell_adhesion | 0.41998779 |
| 122 | MP0000920_abnormal_myelination | 0.41324855 |
| 123 | MP0002132_abnormal_respiratory_system | 0.40439040 |
| 124 | MP0008874_decreased_physiological_sensi | 0.40189401 |
| 125 | MP0006054_spinal_hemorrhage | 0.39849687 |
| 126 | MP0005023_abnormal_wound_healing | 0.39368154 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.38452128 |
| 128 | MP0000609_abnormal_liver_physiology | 0.37818763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.22942138 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.73427897 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.35050502 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.22597665 |
| 5 | Myositis (HP:0100614) | 4.53857768 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.39101014 |
| 7 | Recurrent cutaneous fungal infections (HP:0011370) | 4.16417493 |
| 8 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.16417493 |
| 9 | T lymphocytopenia (HP:0005403) | 4.13000799 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.10992766 |
| 11 | Recurrent skin infections (HP:0001581) | 4.08053028 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 4.07619868 |
| 13 | Obstructive lung disease (HP:0006536) | 4.07619868 |
| 14 | Stomatitis (HP:0010280) | 4.02947189 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.99518344 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.96629777 |
| 17 | Abnormality of T cell number (HP:0011839) | 3.96508773 |
| 18 | IgM deficiency (HP:0002850) | 3.94708454 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.88294361 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.80931185 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.80931185 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 3.80931185 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.74454529 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.67457646 |
| 25 | Anorexia (HP:0002039) | 3.65096029 |
| 26 | Pulmonary embolism (HP:0002204) | 3.64759093 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 3.59956758 |
| 28 | Constricted visual fields (HP:0001133) | 3.59248148 |
| 29 | Recurrent viral infections (HP:0004429) | 3.56755283 |
| 30 | Chronic otitis media (HP:0000389) | 3.51704711 |
| 31 | Severe combined immunodeficiency (HP:0004430) | 3.45579612 |
| 32 | Recurrent bronchitis (HP:0002837) | 3.37845706 |
| 33 | Abnormality of T cells (HP:0002843) | 3.35389420 |
| 34 | Meningitis (HP:0001287) | 3.33854577 |
| 35 | Glomerulonephritis (HP:0000099) | 3.30788235 |
| 36 | Gingivitis (HP:0000230) | 3.28984265 |
| 37 | Chronic diarrhea (HP:0002028) | 3.25702694 |
| 38 | Thyroiditis (HP:0100646) | 3.23715184 |
| 39 | Congenital sensorineural hearing impairment (HP:0008527) | 3.23705198 |
| 40 | Combined immunodeficiency (HP:0005387) | 3.19784058 |
| 41 | Abnormality of alanine metabolism (HP:0010916) | 3.17688862 |
| 42 | Hyperalaninemia (HP:0003348) | 3.17688862 |
| 43 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.17688862 |
| 44 | Gingival bleeding (HP:0000225) | 3.15312463 |
| 45 | Orchitis (HP:0100796) | 3.15278709 |
| 46 | Dysostosis multiplex (HP:0000943) | 3.13642786 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 3.13600139 |
| 48 | Pustule (HP:0200039) | 3.09056884 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 3.04622598 |
| 50 | Optic neuritis (HP:0100653) | 3.04622598 |
| 51 | Leukocytosis (HP:0001974) | 3.04579928 |
| 52 | Abnormality of eosinophils (HP:0001879) | 3.03101492 |
| 53 | Fatigue (HP:0012378) | 2.99218202 |
| 54 | Agnosia (HP:0010524) | 2.97905732 |
| 55 | Myocardial infarction (HP:0001658) | 2.97861608 |
| 56 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.88585918 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.86179282 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.85871714 |
| 59 | Conjunctival telangiectasia (HP:0000524) | 2.85672957 |
| 60 | Vasculitis (HP:0002633) | 2.83676488 |
| 61 | Inflammation of the large intestine (HP:0002037) | 2.83638986 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.83526412 |
| 63 | Thrombocytosis (HP:0001894) | 2.80503512 |
| 64 | IgG deficiency (HP:0004315) | 2.78700487 |
| 65 | Eosinophilia (HP:0001880) | 2.75715211 |
| 66 | Disinhibition (HP:0000734) | 2.72878098 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.70592138 |
| 68 | Petechiae (HP:0000967) | 2.69199915 |
| 69 | Hemoptysis (HP:0002105) | 2.68535589 |
| 70 | Thrombophlebitis (HP:0004418) | 2.67787732 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.62911740 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.62833769 |
| 73 | Nasal polyposis (HP:0100582) | 2.61024390 |
| 74 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.60415254 |
| 75 | Amyloidosis (HP:0011034) | 2.58790571 |
| 76 | Esophageal varix (HP:0002040) | 2.58726779 |
| 77 | Abnormality of T cell physiology (HP:0011840) | 2.55387036 |
| 78 | Lymphopenia (HP:0001888) | 2.53032380 |
| 79 | Hypoplasia of the thymus (HP:0000778) | 2.49443725 |
| 80 | Colitis (HP:0002583) | 2.49127742 |
| 81 | Abnormality of the pleura (HP:0002103) | 2.45593669 |
| 82 | Granulocytopenia (HP:0001913) | 2.41363701 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.41263632 |
| 84 | Basal ganglia calcification (HP:0002135) | 2.40038175 |
| 85 | Gangrene (HP:0100758) | 2.39942938 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 2.39171171 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.39012401 |
| 88 | Cellulitis (HP:0100658) | 2.38837005 |
| 89 | Periodontitis (HP:0000704) | 2.33565342 |
| 90 | Prolonged bleeding time (HP:0003010) | 2.33461110 |
| 91 | Epistaxis (HP:0000421) | 2.31566508 |
| 92 | Axonal loss (HP:0003447) | 2.31073059 |
| 93 | Abnormality of the prostate (HP:0008775) | 2.30893383 |
| 94 | Hematochezia (HP:0002573) | 2.29778368 |
| 95 | Abnormality of the nasal mucosa (HP:0000433) | 2.29189653 |
| 96 | Increased IgM level (HP:0003496) | 2.27449455 |
| 97 | Mucopolysacchariduria (HP:0008155) | 2.26315981 |
| 98 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26315981 |
| 99 | Encephalitis (HP:0002383) | 2.25826295 |
| 100 | Interstitial pulmonary disease (HP:0006530) | 2.25098014 |
| 101 | Abnormality of the pericardium (HP:0001697) | 2.21886471 |
| 102 | Autoimmune hemolytic anemia (HP:0001890) | 2.21751591 |
| 103 | Abnormality of the basal ganglia (HP:0002134) | 2.17708768 |
| 104 | Arterial thrombosis (HP:0004420) | 2.16248448 |
| 105 | Thoracic kyphosis (HP:0002942) | 2.15909888 |
| 106 | Urticaria (HP:0001025) | 2.15202524 |
| 107 | Abnormality of B cell number (HP:0010975) | 2.15114770 |
| 108 | B lymphocytopenia (HP:0010976) | 2.15114770 |
| 109 | Increased IgE level (HP:0003212) | 2.13876757 |
| 110 | Keratoconjunctivitis sicca (HP:0001097) | 2.13836789 |
| 111 | Chest pain (HP:0100749) | 2.13351543 |
| 112 | Loss of speech (HP:0002371) | 2.12031092 |
| 113 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11501441 |
| 114 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11501441 |
| 115 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11501441 |
| 116 | Recurrent sinusitis (HP:0011108) | 2.09240522 |
| 117 | Polyneuropathy (HP:0001271) | 2.08881295 |
| 118 | Cheilitis (HP:0100825) | 2.07045243 |
| 119 | Impaired platelet aggregation (HP:0003540) | 2.06644742 |
| 120 | Abnormal platelet function (HP:0011869) | 2.06644742 |
| 121 | Purpura (HP:0000979) | 2.06385948 |
| 122 | Patchy hypopigmentation of hair (HP:0011365) | 2.03344937 |
| 123 | Pancreatitis (HP:0001733) | 2.02689676 |
| 124 | White forelock (HP:0002211) | 2.01463363 |
| 125 | Restrictive lung disease (HP:0002091) | 1.99331662 |
| 126 | Keratoconjunctivitis (HP:0001096) | 1.98505052 |
| 127 | Hepatosplenomegaly (HP:0001433) | 1.97545000 |
| 128 | Gastrointestinal infarctions (HP:0005244) | 1.96389195 |
| 129 | Cerebral ischemia (HP:0002637) | 1.92833609 |
| 130 | Episodic fever (HP:0001954) | 1.92736024 |
| 131 | Glomerulopathy (HP:0100820) | 1.91733489 |
| 132 | Abnormality of homocysteine metabolism (HP:0010919) | 1.90090915 |
| 133 | Homocystinuria (HP:0002156) | 1.90090915 |
| 134 | Pigmentary retinal degeneration (HP:0001146) | 1.89768162 |
| 135 | Microcytic anemia (HP:0001935) | 1.88035383 |
| 136 | Mucosal telangiectasiae (HP:0100579) | 1.86503592 |
| 137 | Paresthesia (HP:0003401) | 1.80682363 |
| 138 | Peritonitis (HP:0002586) | 1.79145145 |
| 139 | Hyperglycemia (HP:0003074) | 1.78626758 |
| 140 | Vertigo (HP:0002321) | 1.78060072 |
| 141 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.77124223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.37059776 |
| 2 | TXK | 4.08247462 |
| 3 | BLK | 3.20046375 |
| 4 | ACVR1B | 3.12354959 |
| 5 | TGFBR2 | 3.08764412 |
| 6 | IRAK4 | 3.06855665 |
| 7 | TYK2 | 2.89667489 |
| 8 | ZAP70 | 2.80158377 |
| 9 | RIPK4 | 2.79016858 |
| 10 | KIT | 2.68362687 |
| 11 | CSF1R | 2.59533915 |
| 12 | FRK | 2.58958326 |
| 13 | ITK | 2.54122634 |
| 14 | TBK1 | 2.38380297 |
| 15 | MAP3K14 | 2.32846068 |
| 16 | JAK3 | 2.28927262 |
| 17 | IKBKE | 2.15133669 |
| 18 | TEC | 2.12488828 |
| 19 | SYK | 1.87026406 |
| 20 | MAP3K12 | 1.85935524 |
| 21 | NME2 | 1.81071348 |
| 22 | BTK | 1.79639400 |
| 23 | JAK1 | 1.77692231 |
| 24 | FES | 1.75603740 |
| 25 | MAP3K13 | 1.75109002 |
| 26 | STK10 | 1.72171931 |
| 27 | LCK | 1.70740168 |
| 28 | GRK7 | 1.65643411 |
| 29 | HCK | 1.60950821 |
| 30 | CSK | 1.59872350 |
| 31 | GRK6 | 1.51244009 |
| 32 | FLT3 | 1.50413605 |
| 33 | CLK1 | 1.47302871 |
| 34 | IKBKB | 1.42389289 |
| 35 | KDR | 1.41317659 |
| 36 | TRPM7 | 1.39735061 |
| 37 | LYN | 1.36858861 |
| 38 | IRAK3 | 1.36726748 |
| 39 | YES1 | 1.29504779 |
| 40 | MAPK15 | 1.16080444 |
| 41 | NEK9 | 1.15806705 |
| 42 | TESK2 | 1.09345761 |
| 43 | JAK2 | 1.07040380 |
| 44 | TAOK3 | 1.06055894 |
| 45 | FGFR4 | 1.05200850 |
| 46 | MAP2K3 | 1.04003937 |
| 47 | ADRBK2 | 1.01076051 |
| 48 | TSSK6 | 0.90010544 |
| 49 | SGK2 | 0.88868249 |
| 50 | OXSR1 | 0.85013512 |
| 51 | ERN1 | 0.84011624 |
| 52 | PKN2 | 0.83564285 |
| 53 | SIK2 | 0.83474924 |
| 54 | MAP2K6 | 0.80431694 |
| 55 | FGFR3 | 0.79263553 |
| 56 | CDK9 | 0.78011300 |
| 57 | MATK | 0.77190649 |
| 58 | RPS6KA4 | 0.77100679 |
| 59 | NLK | 0.76363211 |
| 60 | SCYL2 | 0.76141924 |
| 61 | FGR | 0.73679118 |
| 62 | MAP3K2 | 0.73060873 |
| 63 | RPS6KB2 | 0.71966985 |
| 64 | CAMKK2 | 0.71825237 |
| 65 | NEK6 | 0.69957634 |
| 66 | VRK1 | 0.68158303 |
| 67 | MAP3K1 | 0.66415190 |
| 68 | MARK3 | 0.65565101 |
| 69 | SGK223 | 0.64493518 |
| 70 | SGK494 | 0.64493518 |
| 71 | PRKCQ | 0.64373314 |
| 72 | PIM1 | 0.62972816 |
| 73 | LRRK2 | 0.61392983 |
| 74 | SGK3 | 0.61281015 |
| 75 | TNK2 | 0.61101901 |
| 76 | PRPF4B | 0.59862649 |
| 77 | PIM2 | 0.59480657 |
| 78 | PDK1 | 0.56622818 |
| 79 | PDPK1 | 0.54515660 |
| 80 | PAK4 | 0.54478737 |
| 81 | SIK3 | 0.52802447 |
| 82 | MAP2K2 | 0.51050619 |
| 83 | STK11 | 0.50651155 |
| 84 | TAOK1 | 0.50639848 |
| 85 | DAPK1 | 0.50470841 |
| 86 | CHUK | 0.49837649 |
| 87 | FYN | 0.48727234 |
| 88 | DAPK2 | 0.48324997 |
| 89 | PRKCD | 0.47967484 |
| 90 | BMPR2 | 0.47751279 |
| 91 | MAPK12 | 0.45771602 |
| 92 | PDK2 | 0.44818787 |
| 93 | MYLK | 0.43433208 |
| 94 | PRKAA2 | 0.43106485 |
| 95 | ILK | 0.42171620 |
| 96 | PASK | 0.40047398 |
| 97 | IGF1R | 0.39342760 |
| 98 | HIPK2 | 0.39241247 |
| 99 | RAF1 | 0.38963925 |
| 100 | MAPKAPK2 | 0.38309263 |
| 101 | CAMKK1 | 0.38096391 |
| 102 | EPHB1 | 0.37911963 |
| 103 | ERBB3 | 0.35930154 |
| 104 | ABL1 | 0.35648768 |
| 105 | MOS | 0.35073549 |
| 106 | MAPK4 | 0.33349250 |
| 107 | ADRBK1 | 0.32873736 |
| 108 | MST4 | 0.31703160 |
| 109 | IRAK1 | 0.30406370 |
| 110 | RPS6KA6 | 0.30314730 |
| 111 | PTK6 | 0.30296769 |
| 112 | PIK3CG | 0.29223284 |
| 113 | STK24 | 0.28948700 |
| 114 | SGK1 | 0.28683357 |
| 115 | EGFR | 0.27900631 |
| 116 | MAP2K1 | 0.26798448 |
| 117 | CDK6 | 0.26724056 |
| 118 | EIF2AK3 | 0.26078514 |
| 119 | IRAK2 | 0.25406917 |
| 120 | MAP3K10 | 0.25200693 |
| 121 | INSR | 0.24159229 |
| 122 | TLK1 | 0.23558012 |
| 123 | PRKG2 | 0.23252483 |
| 124 | RPS6KC1 | 0.22986752 |
| 125 | RPS6KL1 | 0.22986752 |
| 126 | PRKCH | 0.21904908 |
| 127 | CDK19 | 0.20995512 |
| 128 | EEF2K | 0.20563551 |
| 129 | STK4 | 0.20376869 |
| 130 | MAP3K11 | 0.20000686 |
| 131 | MAPK7 | 0.19947449 |
| 132 | EIF2AK1 | 0.18238844 |
| 133 | MAP3K3 | 0.17676093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.46514018 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.88355897 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.87465272 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.83545045 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.68719763 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.62861608 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43016766 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32436640 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.24963327 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.24150611 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.23552506 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20793486 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.11796419 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11425857 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.07881122 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.06220360 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05421084 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 2.04478979 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99278070 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.91684280 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83710586 |
| 22 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.78649793 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.77828007 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.69931717 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.66205702 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58044863 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57000432 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55138086 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53011157 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.51299312 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.42313503 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38715374 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.36836754 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.34040950 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32108884 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.31395125 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.28097745 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.27185871 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25861965 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.24367320 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22818607 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.21018876 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.16914739 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16244004 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13920174 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12278521 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12107864 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.08514829 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06551971 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 1.04810493 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03501006 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 0.98554668 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97664343 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.97641655 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94957121 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94841926 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91572309 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84296535 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80624512 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70751482 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69440474 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69313224 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68406889 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67875254 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67568849 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66562766 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65285462 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64640051 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.64591652 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64029696 |
| 71 | DNA replication_Homo sapiens_hsa03030 | 0.63820000 |
| 72 | Ribosome_Homo sapiens_hsa03010 | 0.62943714 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58509230 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57215711 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.56557137 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56484628 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54330856 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49935756 |
| 79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49342099 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48287724 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48148394 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46242707 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45880281 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45462050 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45329460 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42312190 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40095775 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38142299 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.37430662 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35628050 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33253951 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32730822 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32651139 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32304561 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32022824 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31164321 |
| 97 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30902272 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28990512 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28890894 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27527517 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27404201 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.25903189 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25801663 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25607807 |
| 105 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.25444921 |
| 106 | Renin secretion_Homo sapiens_hsa04924 | 0.25355381 |
| 107 | Protein export_Homo sapiens_hsa03060 | 0.25213934 |
| 108 | Morphine addiction_Homo sapiens_hsa05032 | 0.24930126 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23939619 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23226371 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22736723 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.20669465 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20601028 |
| 114 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.20181134 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.19918750 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19596230 |
| 117 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.19228510 |
| 118 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.19206998 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.18077292 |
| 120 | Mismatch repair_Homo sapiens_hsa03430 | 0.16686625 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.15634253 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15609112 |
| 123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14856133 |
| 124 | Homologous recombination_Homo sapiens_hsa03440 | 0.14846807 |
| 125 | Base excision repair_Homo sapiens_hsa03410 | 0.14393021 |
| 126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13681078 |
| 127 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.12182967 |
| 128 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.11344252 |
| 129 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.10616193 |

